Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences Limited has filed a compliance certificate under SEBI Regulation 74(5) for Q4 FY2025-26 (quarter ended March 31, 2026). The certificate from Registrar and Share Transfer Agent Cameo Corporate Services Limited confirms that securities received for dematerialisation during the quarter were properly processed and accepted/rejected as per regulations. The filing also confirms that physical share certificates were mutilated and cancelled, and depository names were updated in the register of members within the stipulated time limit. This is a routine regulatory filing with no material impact on company operations.
No direct impact on shareholders or stock price. This is a standard SEBI-mandated compliance filing confirming proper processing of share dematerialisation requests, with no bearing on the company's financial performance or business operations.